Integrative AI-metabolomics: a new frontier in diagnosing pulmonary tumor thrombotic microangiopathy.

Amin F, Khalid H, Khalid M, Talha M, Waafira A

Open source

DOI
10.1097/ms9.0000000000003707
Published
2025 Oct
Container
Annals of medicine and surgery (2012)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/ms9.0000000000003707,
  title = {Integrative AI-metabolomics: a new frontier in diagnosing pulmonary tumor thrombotic microangiopathy.},
  author = {Amin F and Khalid H and Khalid M and Talha M and Waafira A},
  year = {2025},
  journal = {Annals of medicine and surgery (2012)},
  doi = {10.1097/ms9.0000000000003707},
  url = {https://doi.org/10.1097/ms9.0000000000003707}
}

RIS

TY  - JOUR
TI  - Integrative AI-metabolomics: a new frontier in diagnosing pulmonary tumor thrombotic microangiopathy.
AU  - Amin F
AU  - Khalid H
AU  - Khalid M
AU  - Talha M
AU  - Waafira A
PY  - 2025
JO  - Annals of medicine and surgery (2012)
DO  - 10.1097/ms9.0000000000003707
UR  - https://doi.org/10.1097/ms9.0000000000003707
ER  - 

APA

F, A., H, K., M, K., M, T., & A, W. (2025). Integrative AI-metabolomics: a new frontier in diagnosing pulmonary tumor thrombotic microangiopathy.. Annals of medicine and surgery (2012). https://doi.org/10.1097/ms9.0000000000003707

Source records